• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

The Economic Burden of Thromboembolic Events Among Patients with Immune-Mediated Diseases
ConclusionAmong patients with IMDs, TEs are associated with substantial economic burden within 30-days and 1-year following the event.
Source: Advances in Therapy - December 14, 2021 Category: Drugs & Pharmacology Source Type: research

Risk of Thromboembolic Events and Associated Healthcare Costs in Patients with Inflammatory Bowel Disease
ConclusionsPatients with IBD experienced greater rates of DVT and PE compared to patients without IMD; this elevated risk was associated with a substantial economic burden.
Source: Advances in Therapy - December 7, 2021 Category: Drugs & Pharmacology Source Type: research